Agencies "failed miserably" over COX-2 inhibitor.
Kermode-Scott
Barbara
B
D002170:Canada; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D017277:Drug Approval; D006077:Government Agencies; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D013450:Sulfones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib